MAD Phase I Study to Investigate Contraloid Acetate

NCT03955380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Dementia
Alzheimer Disease

Interventions

DRUG: Contraloid

Sponsor

Prof. Dr. Dieter Willbold

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]